The transaction, announced in October 2022, represents Betco’s second acquisition in the bioaugmentation field. The company had previously purchased EnviroZyme®, which now operates as a fully owned subsidiary of Betco. The assets acquired from Novozymes will be integrated into EnviroZyme’s overall portfolio.
“This has been a historic venture for our EnviroZyme business,” said Brad Betz, Betco CEO. “We are thrilled with how this acquisition has established EnviroZyme as the number one provider in the wastewater and bioaugmentation industry by fleshing out our breadth of line with these new wastewater business assets and widening our customer base around the world.”
Toledo, Ohio-based Betco Corp. has been manufacturing commercial and institutional cleaning products since 1950. For more information, visit www.betco.com.
Novozymes is a biotech company with a strong focus on enzyme production. Novozymes manufactures more than 700 biotechnology products in 130 countries. For more information, visit www.novozymes.com.